Skip to main content

Personalized neoantigen DNA vaccine

Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors

  • RegistryNCT03988283
  • PhasePhase 1
  • StatusRecruiting
  • ConditionPediatric Recurrent Central Nervous System Tumors
  • SponsorWashington University School of Medicine
How Personalized neoantigen DNA vaccine worksNCT039882831 min

What the film says

Read the transcript

When a brain tumor returns in a teenager or young adult, or is a glioma that never truly goes away, options are few, and none are personal to that tumor.

The idea: read the tumor's own mutations, and write a vaccine against them.

At Washington University in St. Louis, the tumor tissue is sequenced and compared with the patient's normal DNA to find neoantigens, protein fragments made only by the cancer. Those are encoded into a DNA vaccine, delivered into muscle with a brief electrical pulse. Six monthly doses prime the response, then boosters every three months, to train T cells against that specific tumor.

A small first safety study, ages twelve to twenty-five. Michael Huang leads it. Public record; not medical advice.

Sources behind this film

  • ClinicalTrials.gov record NCT03988283

    Recurrent/refractory pediatric CNS tumors; newly diagnosed HGG and DMG eligible; Tumor and normal sequencing to identify neoantigens; DNA vaccine delivered with electroporation device; Six monthly priming doses, then quarterly boosters (+1 more lines)

The drug

What is being tested.

At each vaccination time point, patients will receive one injection of the neoantigen DNA vaccine, one injection into the vastus lateralis.

All study injections will be given intramuscularly using an integrated electroporation device (TDS-IM v2.0 device - Papivax Biotech).

The study

How the trial runs.

The purpose of this research study is to learn about the safety and feasibility of giving a personalized DNA vaccine to people with central nervous system tumors that have returned or have been resistant to treatment.

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Step 1 Eligibility Criteria for Tissue Sequencing
  • Any patient between the ages of 12 and 25 years of age (inclusive) who was diagnosed with any of the following:
  • High-grade glioma (HGG); newly diagnosed patients
  • Diffuse midline glioma (DMG); newly diagnosed patients
  • A pediatric CNS (brain or spine) tumor of any histologic subtype, who has now developed recurrent or refractory disease.
  • All patients enrolled in this trial will receive treatment for pediatric CNS tumors, including systemic agents, investigational agents, or radiation therapy, prior to receiving the neoantigen DNA vaccine. Co-enrollment to another interventional clinical trial is permitted during the vaccine manufacture period.

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.